Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Bukowski

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Seminars in Arthritis and Rheumatism|December 24, 2014
The burden of non-radiographic axial spondyloarthritisAnnelies Boonen, Joachim Sieper, Désirée van der Heijde, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2019
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal AntibodiesEllen Q Wang, Jack F Bukowski, Carla Yunis, et al.
Arthritis Research & Therapy|June 8, 2017
MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammationWalter P Maksymowych, Stephanie Wichuk, Maxime Dougados, et al.
Drugs & Aging|July 12, 2019
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled TrialsChristopher J Edwards, Katherine Roshak, Jack F Bukowski, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritisWalter P Maksymowych, Stephanie Wichuk, Maxime Dougados, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cellsHong Wang, Hoi K Lee, Jack F Bukowski, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variationsMukundan Attur, Hwa-Ying Wang, Virginia Byers Kraus, et al.
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK studyWalter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Seminars in Arthritis and Rheumatism|December 24, 2014
The burden of non-radiographic axial spondyloarthritisAnnelies Boonen, Joachim Sieper, Désirée van der Heijde, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2019
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal AntibodiesEllen Q Wang, Jack F Bukowski, Carla Yunis, et al.
Arthritis Research & Therapy|June 8, 2017
MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammationWalter P Maksymowych, Stephanie Wichuk, Maxime Dougados, et al.
Drugs & Aging|July 12, 2019
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled TrialsChristopher J Edwards, Katherine Roshak, Jack F Bukowski, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritisWalter P Maksymowych, Stephanie Wichuk, Maxime Dougados, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cellsHong Wang, Hoi K Lee, Jack F Bukowski, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variationsMukundan Attur, Hwa-Ying Wang, Virginia Byers Kraus, et al.
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK studyWalter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Pageof 3